Navigation Links
Navigating the Patent Minefield of Embryonic Stem Cell Product Development; Free Kindle Fire Tablet and Research Database with Purchase

FARMINGTON, Conn., May 31, 2012 /PRNewswire-iReach/ -- BioInformant's two newest market researchs report offers mission-critical insight into the complex but lucrative world of embryonic stem cell product development and patent licensing. To promote these excellent products, Global Information Inc is offering our first 10 customers an Amazon Kindle Fire tablet with their purchase, as well as a copy of BioInformant's 2012 Marketing Database of Stem Cell Researchers, a combined $1500 value, absolutely free.


Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products

Companies interested in developing human embryonic stem cell products have to navigate a risky product environment. Due to the long-standing and controversial patents held by the University of Wisconsin's Alumni Research Foundation (WARF), companies have been largely hindered by the intellectual property (IP) environment restricting the development of embryonic stem cell products.  However, going where competitors fear to tread means tremendous financial rewards are available for the companies that move boldly forward.

Human embryonic stem cells offer tremendous therapeutic potential, as they can develop into over 200 different cell types. However, up until now, WARF has had the power to largely control what companies can develop embryonic stem cell products and on what terms. With the release of BioInformant's report Error-Proof Entry, Expert Positioning, and Exploding Growth in Embryonic Stem Cell Products, published June 2012, research supply companies can now receive clear guidance for navigating the hazards of embryonic stem cell product development.

The report reveals critical alternatives to traditional WARF licensing, such as moving research overseas, establishing collaborations with companies that are existing WARF licensees, structuring creative negotiating alternatives, developing products for other species – and other breakthrough strategies.

BioInformant's report also offers historical and future growth projections for the embryonic stem cell product market, competitive analysis of existing providers, and detailed assessment of creative strategies for developing high-demand products.  This insight is possible, because BioInformant has been the global leader in stem cell industry data since 2006 and is the only producer of market intelligence data specific for the stem cell sector.

Free samples from the full document are available at:

Stem Cell Research Products - Opportunities, Tools, and Technologies

Staying ahead of a hungry and fast moving pack of competitors requires the very best market insights, and BioInformant also offers a sophisticated market intelligence report for the stem cell research supply market.

Whether you already supply stem cell research products or you wish to expand your product line, you'll know just how essential and lucrative this market is. We know you want to make effective product development decisions, to sell more effectively to scientists, to generate improved revenues and take market share from your competition.

Stem Cell Research Products - Opportunities, Tools, and Technologies - published in May 2012 - shows you how to do just that. Helping you understand the prevailing market conditions and giving you guidance to strategically position and develop stem cell product lines.

So when you choose our industry-leading market report, you'll be gaining a competitive advantage in three core areas.

To see the details of those core areas, and to view free samples from the full document, please visit the report page at:

About Global Information Inc. - Global Information (GII) ( is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia, Global Information, Inc., 1-860-674-8796,

News distributed by PR Newswire iReach:

SOURCE Global Information, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Navigating the IP Minefield of Human Embryonic Stem Cell Development
2. Navigating in the ocean of molecules
3. Medbox Developing a Patent Pending Wall-Mounted Biometric Kiosk for Storage of Sensitive Medicine Samples and Supplies for Doctors Offices.
4. How will the US biotechnology industry benefit from new patent laws?
5. NJIT professor awarded patent today for new desalination devices, more
6. Improved Authentication and Confidentiality Protection. ICAP Patent Brokerage Announces for Auction Important Patents in Data Encryption and Document Security
7. Alnylam and UMass Medical School announce Tuschl I patent upheld in European opposition proceedings
8. IVI granted 2 US patents on dysentery vaccine inventions
9. St. Michaels and King Saud University receive first joint patent
10. Psychemedics Awarded Patent Fundamental To Hair Analysis Drug Testing
11. UCF patented on induced pluripotent stem cells, iPS cells
Post Your Comments:
(Date:6/16/2016)... The global Biometric ... USD 1.83 billion by 2024, according to a ... proliferation and increasing demand in commercial buildings, consumer ... the market growth.      (Logo: ... of advanced multimodal techniques for biometric authentication and ...
(Date:6/9/2016)... leader in attendance control systems is proud to announce the introduction of fingerprint attendance ... the right employees are actually signing in, and to even control the opening of ... ... ... Photo - ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... - FACIT has announced the creation of a ... Propellon Therapeutics Inc. ("Propellon" or "the Company"), to ... of first-in-class WDR5 inhibitors for the treatment of ... an exciting class of therapies, possessing the potential ... patients. Substantial advances have been achieved with the ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm Sciences, Inc. is ... has received AOAC Research Institute approval 061601. , “This is another AOAC-RI approval ... Bob Salter, Vice President of Regulatory and Industrial Affairs. “The Peel Plate methods ...
(Date:6/23/2016)... , June 23, 2016   EpiBiome , ... secured $1 million in debt financing from Silicon Valley ... up automation and to advance its drug development efforts, ... new facility. "SVB has been an incredible ... the services a traditional bank would provide," said Dr. ...
(Date:6/23/2016)... ... ... In a new case report published today in STEM CELLS Translational Medicine, ... after being treated for breast cancer benefitted from an injection of stem cells derived ... debilitating, frequent side effect of cancer treatment. , Lymphedema refers to the ...
Breaking Biology Technology: